The Limited Times

Now you can see non-English news...

Covid: WHO homologous Chinese single-dose vaccine Convidecia

2022-05-19T12:45:48.321Z

The World Health Organization (WHO) today announced the emergency approval of the anti-Covid vaccine Convidecia from the Chinese laboratories CanSino Biologics. (HANDLE)



(ANSA) - GENEVA, MAY 19 - The World Health Organization (WHO) today announced the emergency approval of the anti-Covid vaccine Convidecia of the Chinese laboratories CanSinoBiologics.

The vaccine is based on a human-modified adenovirus, is administered in a single dose and the WHO recommends it for all ages starting from 18, according to a UN organization statement.

(HANDLE).


Source: ansa

All life articles on 2022-05-19

Similar news:

You may like

Life/Entertain 2022-02-18T08:50:59.251Z

Trends 24h

Life/Entertain 2022-07-06T23:59:35.859Z
Life/Entertain 2022-07-07T02:59:26.175Z

Latest

© Communities 2019 - Privacy